The Need for Improved Methodology in Protein Corona Analysis

Overview

Journal Nat Commun

Specialty Biology

Date 2022 Jan 11

PMID 35013179

Authors

Morteza Mahmoudi

Affiliations

Soon will be listed here.

Citing Articles

Protein Corona of Nanoparticles: Isolation and Analysis.

Sun Y, Zhou Y, Rehman M, Wang Y, Guo S Chem Bio Eng. 2025; 1(9):757-772.

PMID: 39974182 PMC: 11792916. DOI: 10.1021/cbe.4c00105.

Small molecule modulation of protein corona for deep plasma proteome profiling.

Ashkarran A, Gharibi H, Sadeghi S, Modaresi S, Wang Q, Lin T Nat Commun. 2024; 15(1):9638.

PMID: 39511193 PMC: 11544298. DOI: 10.1038/s41467-024-53966-z.

The role of protein corona in advancing plasma proteomics.

Saei A, Sun L, Mahmoudi M Proteomics. 2024; 25(1-2):e2400028.

PMID: 39221533 PMC: 11735278. DOI: 10.1002/pmic.202400028.

Protocols for isolation and characterization of nanoparticle biomolecular corona complexes.

Soliman M, Martinez-Serra A, Dobricic M, Trinh D, Cheeseman J, Spencer D Front Toxicol. 2024; 6:1393330.

PMID: 39109300 PMC: 11301017. DOI: 10.3389/ftox.2024.1393330.

Standardizing Protein Corona Characterization in Nanomedicine: A Multicenter Study to Enhance Reproducibility and Data Homogeneity.

Ashkarran A, Gharibi H, Modaresi S, Saei A, Mahmoudi M Nano Lett. 2024; 24(32):9874-9881.

PMID: 39096192 PMC: 11328176. DOI: 10.1021/acs.nanolett.4c02076.

References

Danaei M, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A . Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems. Pharmaceutics. 2018; 10(2). PMC: 6027495. DOI: 10.3390/pharmaceutics10020057. View

Saei A, Sharifi S, Mahmoudi M . COVID-19: Nanomedicine Uncovers Blood-Clot Mystery. J Proteome Res. 2020; 19(11):4364-4373. DOI: 10.1021/acs.jproteome.0c00425. View

Haid M, Muschet C, Wahl S, Romisch-Margl W, Prehn C, Moller G . Long-Term Stability of Human Plasma Metabolites during Storage at -80 °C. J Proteome Res. 2017; 17(1):203-211. DOI: 10.1021/acs.jproteome.7b00518. View

Sheibani S, Basu K, Farnudi A, Ashkarran A, Ichikawa M, Presley J . Nanoscale characterization of the biomolecular corona by cryo-electron microscopy, cryo-electron tomography, and image simulation. Nat Commun. 2021; 12(1):573. PMC: 7835367. DOI: 10.1038/s41467-020-20884-9. View

Tabb D, Vega-Montoto L, Rudnick P, Variyath A, Ham A, Bunk D . Repeatability and reproducibility in proteomic identifications by liquid chromatography-tandem mass spectrometry. J Proteome Res. 2009; 9(2):761-76. PMC: 2818771. DOI: 10.1021/pr9006365. View

Monopoli M, Aberg C, Salvati A, Dawson K . Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol. 2012; 7(12):779-86. DOI: 10.1038/nnano.2012.207. View

Monopoli M, Walczyk D, Campbell A, Elia G, Lynch I, Bombelli F . Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc. 2011; 133(8):2525-34. DOI: 10.1021/ja107583h. View

Lhoest J, Detrait E, van den Bosch de Aguilar P, Bertrand P . Fibronectin adsorption, conformation, and orientation on polystyrene substrates studied by radiolabeling, XPS, and ToF SIMS. J Biomed Mater Res. 1998; 41(1):95-103. DOI: 10.1002/(sici)1097-4636(199807)41:1<95::aid-jbm12>3.0.co;2-g. View

Park K . The beginning of the end of the nanomedicine hype. J Control Release. 2019; 305:221-222. DOI: 10.1016/j.jconrel.2019.05.044. View

10.

Kristensen K, Munter R, Kempen P, Thomsen M, Stensballe A, Andresen T . Isolation methods commonly used to study the liposomal protein corona suffer from contamination issues. Acta Biomater. 2021; 130:460-472. DOI: 10.1016/j.actbio.2021.06.008. View

11.

Hajipour M, Laurent S, Aghaie A, Rezaee F, Mahmoudi M . Personalized protein coronas: a "key" factor at the nanobiointerface. Biomater Sci. 2020; 2(9):1210-1221. DOI: 10.1039/c4bm00131a. View

12.

Mahmoudi M, Abdelmonem A, Behzadi S, Clement J, Dutz S, Ejtehadi M . Temperature: the "ignored" factor at the NanoBio interface. ACS Nano. 2013; 7(8):6555-62. DOI: 10.1021/nn305337c. View

13.

Dawson K, Yan Y . Current understanding of biological identity at the nanoscale and future prospects. Nat Nanotechnol. 2021; 16(3):229-242. DOI: 10.1038/s41565-021-00860-0. View

14.

Papafilippou L, Claxton A, Dark P, Kostarelos K, Hadjidemetriou M . Nanotools for Sepsis Diagnosis and Treatment. Adv Healthc Mater. 2020; 10(1):e2001378. PMC: 11469323. DOI: 10.1002/adhm.202001378. View

15.

Mahmoudi M . The need for robust characterization of nanomaterials for nanomedicine applications. Nat Commun. 2021; 12(1):5246. PMC: 8413343. DOI: 10.1038/s41467-021-25584-6. View

16.

Schottler S, Klein K, Landfester K, Mailander V . Protein source and choice of anticoagulant decisively affect nanoparticle protein corona and cellular uptake. Nanoscale. 2016; 8(10):5526-36. DOI: 10.1039/c5nr08196c. View

17.

Faria M, Bjornmalm M, Thurecht K, Kent S, Parton R, Kavallaris M . Minimum information reporting in bio-nano experimental literature. Nat Nanotechnol. 2018; 13(9):777-785. PMC: 6150419. DOI: 10.1038/s41565-018-0246-4. View

18.

Nowak J, Watala C, Boncler M . Antibody binding, platelet adhesion, and protein adsorption on various polymer surfaces. Blood Coagul Fibrinolysis. 2013; 25(1):52-60. DOI: 10.1097/MBC.0b013e328364a802. View

19.

Leong H, Butler K, Brinker C, Azzawi M, Conlan S, Dufes C . On the issue of transparency and reproducibility in nanomedicine. Nat Nanotechnol. 2019; 14(7):629-635. PMC: 6939883. DOI: 10.1038/s41565-019-0496-9. View